Ep 14 | All About 340B Grantees (Part 2)
340B Unscripted6 Maalis 2023

Ep 14 | All About 340B Grantees (Part 2)

This is part two of our two-part series focusing on 340B grantee-covered entities. The team talks about the importance of maintaining auditable records (15:34) and the challenges that many grantees face in meeting this 340B eligibility requirement. Also, they cover important billing considerations related to Medicaid Duplicate Discount prevention (31:20). Finally, the group debates future developments that 340B grantee-covered entities should keep on their radar through 2023 (45:52).

But first, Greg and Rob catch up on 340B implications from the Consolidated Appropriations Act of 2023 and share insights from a recent publication (J Manag Care Spec Pharm. 2023;29(3):229-35) that predicts which drugs will be subject to Medicare price negotiations starting in 2026 and beyond.

Jaksot(91)

Ep 61 | What Else is Happening in 340B to Start 2025

Ep 61 | What Else is Happening in 340B to Start 2025

In this week’s episode, Greg and Rob catch up on newsworthy developments in the 340B community. They’ll discuss various state and federal legislative developments, they’ll share how recent White House...

3 Helmi 202534min

Ep 60 | What’s Happening in 340B to Start 2025

Ep 60 | What’s Happening in 340B to Start 2025

In our first episode of 2025, Greg and Rob discuss the latest developments in 340B. They’ll recap HRSA audit trends, discuss how Congressional committee membership seems to be forming, and discuss a v...

15 Tammi 202548min

Ep 59 | Recap of 340B Developments in 2024

Ep 59 | Recap of 340B Developments in 2024

In our last episode of 2024, Greg and Rob recap major developments in the 340B space from the last year.  They’ll start with trends in HRSA audit activity, including thoughts on patient definition. Th...

17 Joulu 20241h 2min

Ep 58 | Sanofi 340B Credit Model

Ep 58 | Sanofi 340B Credit Model

In this week’s episode, Greg and Rob cover the recent policy notice put out by Sanofi regarding a 340B credit model. They discuss how it compares to other proposed credit/rebate models, and more impor...

2 Joulu 202451min

Ep 57 | Post-Election Outcome & 340B Implications

Ep 57 | Post-Election Outcome & 340B Implications

In this episode, Greg and Rob are joined by Rodney Whitlock, healthcare policy expert, to discuss the recent 2024 election results.    They’ll discuss what the second Trump Administration might priori...

14 Marras 202454min

Ep 56 | 2024 General Election Outlook & 340B

Ep 56 | 2024 General Election Outlook & 340B

In this episode, Greg and Rob are joined by Mike Strazzella, government affairs expert from Buchanan Ingersoll & Rooney, to discuss the upcoming general election, and what races may be critical to fut...

28 Loka 202455min

Ep 55 | All About 340B Modifiers

Ep 55 | All About 340B Modifiers

In this episode, Greg and Rob discuss the various uses of 340B billing modifiers. They’ll discuss some general considerations around what billing modifiers are used for, highlight differences between ...

14 Loka 202458min

Ep 54 | 340B Operations Discussion – “Clean Site” Locations

Ep 54 | 340B Operations Discussion – “Clean Site” Locations

In this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations.  They discuss what “clean site” means in the world of 340B, what t...

1 Loka 202450min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-rahamania
rss-lahtijat
ostan-asuntoja-podcast
rahapuhetta
rss-neuvottelija-sami-miettinen
rss-h-asselmoilanen
rss-laakispodi
inderespodi
rss-porssipuhetta
rss-startup-ministerio
rss-bisnesta-bebeja
sijoituspodi
rss-strategian-seurassa
asuntoasiaa-paivakirjat
rss-merja-mahkan-rahat
rss-paasipodi